Application Notes & Case Studies

  1. Clarification & Prefiltration In Biopharm Formulation And Filling 6/22/2026

    Improve biopharma workflows with clarification and prefiltration that cut particulates and bioburden, protect downstream steps, and maintain protein product integrity.

  2. Particle Removal In Drug Production 6/22/2026

    Optimize particle removal with filtration strategies tailored to process conditions, boosting efficiency, protecting product quality, and reducing contamination risk in small molecule manufacturing.

  3. The Benefits Of Aqueous Critical Cleaning 6/22/2026

    Enhance pharmaceutical cleaning by aligning chemistry, process design, and monitoring to remove complex residues, reduce contamination risk, and ensure consistent, compliant performance.

  4. Discover A System That Can Be Used With Various Cell Culture Media 6/19/2026

    Evolving CAR T cell therapies are raising the bar for manufacturing. Advances in cell expansion and the shift to serum-free media are redefining how scalable, future-ready processes are designed.

  5. Developing CAR T Therapies With A Cell Therapy Manufacturing Platform 6/19/2026

    Advances in CAR T cell engineering are expanding clinical potential, but manufacturing complexity limits scale. Integrated, automated workflows offer a path to consistent and efficient production.

  6. Characterization Of Antibody-Drug Conjugate Critical Quality Attributes 6/18/2026

    Accurate assessment of DAR and aggregation is key to ADC quality. Multi-temperature UV-Vis analysis enables efficient measurements with simplified workflows, helping teams make confident decisions.

  7. Analysis Of ADCs Using Hydrophobic Interaction Chromatography 6/18/2026

    Accurate DAR analysis in HIC requires systems that withstand corrosive salt conditions. Bioinert flow paths and baseline correction tools improve reproducibility, enabling confident characterization of ADCs.

  8. Characterization Of Antibody‑Drug Conjugates Using 2D-LC And Native MS 6/18/2026

    Accurate DAR measurement is critical for ADC performance, yet traditional methods can compromise integrity. See how an MS workflow combining HIC, heart-cutting, and SEC enables more reliability.

  9. Analysis Of Free Drug Content In Antibody-Drug Conjugate 6/18/2026

    Free drug content can compromise ADC safety and performance if not carefully measured. A multidimensional LC/Q-TOF workflow pairs SEC and reversed-phase separation to enable sensitive detection.

  10. Protein And Payload Stability Of Brentuximab Vedotin In Monkey Plasma 6/18/2026

    Examine an approach that enables precise measurement of protein and payload stability for antibody–drug conjugates in plasma, helping researchers better understand molecular behavior over time.